In 199 evaluable tumours, high nuclear Mre11 (Fig. 1a) was associated with serous cystadenocarcinoma (p < 0.001) and high FIGO stage (p = 0.002) (Supplementary Table 2). This evidence concerns the gene MRE11 and cystadenocarcinoma.